190 related articles for article (PubMed ID: 30696584)
1. The reproductive life cycle of cancer: Hypotheses of cell of origin, TP53 drivers and stem cell conversions in the light of the atavistic cancer cell theory.
Niculescu VF
Med Hypotheses; 2019 Feb; 123():19-23. PubMed ID: 30696584
[TBL] [Abstract][Full Text] [Related]
2. aCLS cancers: Genomic and epigenetic changes transform the cell of origin of cancer into a tumorigenic pathogen of unicellular organization and lifestyle.
Niculescu VF
Gene; 2020 Feb; 726():144174. PubMed ID: 31647999
[TBL] [Abstract][Full Text] [Related]
3. Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells.
Niu N; Mercado-Uribe I; Liu J
Oncogene; 2017 Aug; 36(34):4887-4900. PubMed ID: 28436947
[TBL] [Abstract][Full Text] [Related]
4. The dualistic origin of human tumors.
Liu J
Semin Cancer Biol; 2018 Dec; 53():1-16. PubMed ID: 30040989
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
6. CoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancer.
Lopez-Sánchez LM; Jimenez C; Valverde A; Hernandez V; Peñarando J; Martinez A; Lopez-Pedrera C; Muñoz-Castañeda JR; De la Haba-Rodríguez JR; Aranda E; Rodriguez-Ariza A
PLoS One; 2014; 9(6):e99143. PubMed ID: 24932611
[TBL] [Abstract][Full Text] [Related]
7. The "life code": A theory that unifies the human life cycle and the origin of human tumors.
Liu J
Semin Cancer Biol; 2020 Feb; 60():380-397. PubMed ID: 31521747
[TBL] [Abstract][Full Text] [Related]
8. TP53 mutations, expression and interaction networks in human cancers.
Wang X; Sun Q
Oncotarget; 2017 Jan; 8(1):624-643. PubMed ID: 27880943
[TBL] [Abstract][Full Text] [Related]
9. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
[TBL] [Abstract][Full Text] [Related]
10. Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.
Olivos DJ; Mayo LD
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898034
[TBL] [Abstract][Full Text] [Related]
11. iTRAQ-based proteomic analysis of polyploid giant cancer cells and budding progeny cells reveals several distinct pathways for ovarian cancer development.
Zhang S; Mercado-Uribe I; Hanash S; Liu J
PLoS One; 2013; 8(11):e80120. PubMed ID: 24348907
[TBL] [Abstract][Full Text] [Related]
12. The paradigm of mutant p53-expressing cancer stem cells and drug resistance.
Shetzer Y; Solomon H; Koifman G; Molchadsky A; Horesh S; Rotter V
Carcinogenesis; 2014 Jun; 35(6):1196-208. PubMed ID: 24658181
[TBL] [Abstract][Full Text] [Related]
13. Neosis: a novel type of cell division in cancer.
Sundaram M; Guernsey DL; Rajaraman MM; Rajaraman R
Cancer Biol Ther; 2004 Feb; 3(2):207-18. PubMed ID: 14726689
[TBL] [Abstract][Full Text] [Related]
14. Generation of Polyploid Giant Cancer Cells (PGCCs) from Hey Ovarian Cancer Cells and Analysis of Embryonic Properties.
Niu N; Liu J
Methods Mol Biol; 2024; 2825():281-292. PubMed ID: 38913316
[TBL] [Abstract][Full Text] [Related]
15. Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.
Blackburn J; Roden DL; Ng R; Wu J; Bosman A; Epstein RJ
Mol Carcinog; 2016 Dec; 55(12):1940-1951. PubMed ID: 26676339
[TBL] [Abstract][Full Text] [Related]
16. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
17. Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer.
Chen J; Niu N; Zhang J; Qi L; Shen W; Donkena KV; Feng Z; Liu J
Curr Cancer Drug Targets; 2019; 19(5):360-367. PubMed ID: 29968537
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
[TBL] [Abstract][Full Text] [Related]
19. Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells.
Motohara T; Masuko S; Ishimoto T; Yae T; Onishi N; Muraguchi T; Hirao A; Matsuzaki Y; Tashiro H; Katabuchi H; Saya H; Nagano O
Carcinogenesis; 2011 Nov; 32(11):1597-606. PubMed ID: 21828057
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.
Samuel N; Wilson G; Id Said B; Pan A; Deblois G; Fischer NW; Alexandrova R; Casallo G; Paton T; Lupien M; Gariepy J; Merico D; Hudson TJ; Malkin D
Oncotarget; 2016 Aug; 7(31):49611-49622. PubMed ID: 27391063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
